delphinidin has been researched along with Cardiovascular Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barmeyer, J | 1 |
| Andriantsitohaina, R; Boursier, J; Clere, N; Dayoub, O; Dubois, S; Gagnadoux, F; Hilairet, G; Le Lay, S; Martínez, MC; Soleti, R | 1 |
| Andriantsitohaina, R; Clere, N; Dayoub, O | 1 |
1 review(s) available for delphinidin and Cardiovascular Diseases
| Article | Year |
|---|---|
Pleiotropic beneficial effects of epigallocatechin gallate, quercetin and delphinidin on cardiovascular diseases associated with endothelial dysfunction.
Topics: Anthocyanins; Antioxidants; Apoptosis; Cardiovascular Diseases; Catechin; Endothelium, Vascular; Humans; Quercetin; Reactive Oxygen Species | 2013 |
2 other study(ies) available for delphinidin and Cardiovascular Diseases
| Article | Year |
|---|---|
[A simple method for measuring the post mortem flow of intercoronary anastomoses].
Topics: Blood Volume Determination; Cadaver; Cardiovascular Diseases; Coronary Circulation; Coronary Vessels; Heart; Humans; Methods; Organ Size; Paraffin; Perfusion; Petroleum; Regional Blood Flow | 1971 |
Estrogen receptor α/HDAC/NFAT axis for delphinidin effects on proliferation and differentiation of T lymphocytes from patients with cardiovascular risks.
Topics: Anthocyanins; Calcium; Calcium Signaling; Cardiovascular Diseases; Cell Cycle; Cell Differentiation; Cell Proliferation; Cells, Cultured; Estrogen Receptor alpha; Histone Deacetylases; Humans; Lymphocyte Activation; MAP Kinase Signaling System; NFATC Transcription Factors; Risk Factors; Signal Transduction; T-Lymphocyte Subsets; T-Lymphocytes | 2017 |